Pediatric Immunology Department, Getafe Hospital, Madrid, Spain.
HIV Med. 2010 Apr;11(4):245-52. doi: 10.1111/j.1468-1293.2009.00768.x. Epub 2009 Dec 28.
Highly active antiretroviral therapy (HAART) has dramatically changed the natural history of HIV infection in children, but there are few studies in the literature about the incidence of clinical manifestations after HAART in this population, compared with adults. The aim of this study was to describe the influence of the widespread use of HAART on the development of opportunistic infections and organ-specific diseases in HIV-infected children.
An observational study of a cohort of 366 vertically HIV-infected children followed from 1990 to 2006 was carried out. According to the main antiretroviral protocol used, three calendar periods (CPs) were defined and compared: CP1 (1990-1996: no patients on HAART), CP2 (1997-1999: <60% on HAART) and CP3 (2000-2006: >60% on HAART).
Children experienced a progressive increase in CD4 T cell count (P<0.05) and a decrease in HIV viral load from 1996 onwards (P<0.05). Similarly, rates of death, AIDS, opportunistic infections (bacteraemia, candidosis, cryptosporidiosis and bacterial pneumonia) and organ-specific diseases (wasting syndrome, thrombocytopenia, cardiomyopathy, lymphoid interstitial pneumonia and HIV-associated encephalopathy) were lower in CP2 and CP3 than in CP1.
This study provides evidence of improved clinical outcomes in HIV-infected children over time and shows that mortality, AIDS, opportunistic infections and organ-specific diseases declined as HAART was progressively instituted in this population.
高效抗逆转录病毒疗法(HAART)极大地改变了儿童 HIV 感染的自然史,但与成人相比,文献中关于该人群接受 HAART 后临床表现发生率的研究较少。本研究旨在描述 HAART 的广泛应用对 HIV 感染儿童机会性感染和器官特异性疾病发展的影响。
对 1990 年至 2006 年期间接受垂直 HIV 感染的 366 例儿童进行了队列观察研究。根据主要使用的抗逆转录病毒方案,定义了三个日历期(CP)并进行了比较:CP1(1990-1996:无患者接受 HAART)、CP2(1997-1999:<60%接受 HAART)和 CP3(2000-2006:>60%接受 HAART)。
儿童的 CD4 T 细胞计数逐渐增加(P<0.05),从 1996 年开始 HIV 病毒载量下降(P<0.05)。同样,在 CP2 和 CP3 中,死亡、艾滋病、机会性感染(菌血症、念珠菌病、隐孢子虫病和细菌性肺炎)和器官特异性疾病(消瘦综合征、血小板减少症、心肌病、淋巴间质肺炎和 HIV 相关性脑病)的发生率低于 CP1。
本研究提供了 HIV 感染儿童随时间改善临床结局的证据,并表明随着 HAART 在该人群中的逐步实施,死亡率、艾滋病、机会性感染和器官特异性疾病有所下降。